Functional Mushrooms for Women: Hormones, Mood, and Menopause

Women experience depression at twice the rate of men. Hormonal transitions — perimenopause, postpartum, PMS — drive much of this disparity. Here's what functional mushrooms offer.

The Gender Gap in Depression

Women are diagnosed with depression at approximately twice the rate of men. This disparity is not fully explained by differences in help-seeking behaviour or diagnostic bias — it reflects genuine biological differences in vulnerability, driven largely by hormonal fluctuations that affect serotonin, dopamine, and GABA systems throughout the female lifespan.

The periods of highest vulnerability are well-documented: the premenstrual phase (PMDD affects 3–8% of women of reproductive age), the postpartum period (postpartum depression affects 10–15% of new mothers), and the perimenopause transition (depression rates increase 2–4 fold during perimenopause). Each of these periods involves rapid changes in oestrogen and progesterone — hormones that directly modulate the same neurotransmitter systems that functional mushrooms target.

Oestrogen, Serotonin, and Psilocybin

Oestrogen upregulates serotonin synthesis, increases serotonin receptor density, and enhances serotonin transporter function. When oestrogen drops — as it does premenstrually, postpartum, and during perimenopause — serotonin function drops with it. This is why SSRIs are effective for PMDD and postpartum depression, and why the perimenopause transition is a high-risk period for first-onset depression.

Psilocybin acts directly on serotonin 2A receptors, bypassing the upstream oestrogen-serotonin synthesis pathway. This means psilocybin's antidepressant effects may be less dependent on oestrogen levels than SSRI effects — a potentially significant advantage for women whose depression is driven by hormonal fluctuation rather than baseline serotonin deficiency.

A 2023 observational study found that women in perimenopause who used psilocybin (in naturalistic settings) reported significant improvements in mood, sleep, and cognitive function, with particular benefit for the emotional volatility and depressive symptoms associated with the transition. Controlled trials in perimenopausal women are currently underway at Johns Hopkins and UCSF.

Lion's Mane and Cognitive Protection

Cognitive changes during perimenopause — brain fog, memory difficulties, reduced processing speed — are among the most distressing symptoms for many women. These changes are driven by declining oestrogen, which plays a neuroprotective role in the hippocampus and prefrontal cortex.

Lion's mane mushroom stimulates nerve growth factor (NGF) production — a protein that supports neuronal survival and synaptic plasticity in precisely the brain regions affected by oestrogen withdrawal. A 2020 study found that lion's mane supplementation improved cognitive performance in women aged 50–65, with the greatest benefit in those with the lowest baseline cognitive scores.

Reishi and Hormonal Balance

Reishi mushroom contains compounds that modulate the hypothalamic-pituitary-adrenal (HPA) axis — the stress response system that is frequently dysregulated in women with hormonal mood disorders. Chronic HPA activation (elevated cortisol) suppresses oestrogen production and disrupts the oestrogen-serotonin axis, creating a vicious cycle of stress, hormonal disruption, and mood deterioration.

A 2012 study found that reishi supplementation significantly reduced cortisol levels and improved mood in women with stress-related fatigue. The adaptogenic properties of reishi — its ability to modulate the stress response in both directions — make it particularly relevant for women navigating hormonal transitions.

This article is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before making any changes to your health regimen.